Pharmacodynamic Assessment of Cefprozil against Streptococcus pneumoniae: Implications for Breakpoint Determinations

Cefprozil, an oral semisynthetic cephalosporin, is commonly utilized in the treatment of respiratory-tract infections in children. While this agent has provided acceptable clinical success over a number of years, this study was undertaken to better define its pharmacodynamic profile against Streptoc...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Nicolau, David P., Onyeji, Cyprian O., Zhong, Mingkang, Tessier, Pamela R., Banevicius, Mary Anne, Nightingale, Charles H.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2000
Matèries:	Experimental Therapeutics
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89857/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10770764/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.5.1291-1295.2000
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!